On September 2, 2026, Lawrence Leisure notified the Board of Directors of DarioHealth Corp. that he would retire from his position as a director, effective immediately, for personal reasons. The company confirmed that this departure was not due to any disagreement regarding operations or policies. DarioHealth Corp. operates in the digital health industry, providing remote patient monitoring and chronic care management solutions.

DarioHealth Corp. announced that Steven Nelson will cease serving as President and Chief Commercial Officer effective September 1, 2026, with his employment terminating on September 30, 2026. The separation agreement includes payment of earned wages, continued health insurance through the separation date, and COBRA reimbursement of $2,600 monthly for up to three months. Unvested equity awards will expire upon termination. Nelson will transition into a consulting role effective October 1, 2026, providing advisory services through December 31, 2027, in exchange for 30,000 shares of restricted common stock vesting on the first anniversary of the grant date. DarioHealth Corp. operates in the digital health industry, providing remote patient monitoring and chronic disease management solutions.

On July 22, 2026, DarioHealth Corp. entered into a Securities Purchase Agreement for a registered direct offering to raise approximately $23.5 million in gross proceeds. The offering consists of 2,437,060 shares of common stock priced at $6.80 per share and pre-funded warrants for 1,017,499 shares priced at $6.7999 per warrant. Additionally, board member Dennis Matheis agreed to purchase 14,430 shares at $6.93 per share. The offering is expected to close around July 23, 2026, with proceeds intended for working capital, investments, acquisitions, and general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent, receiving a cash fee of 6.0% of gross proceeds, with a 1.0% fee for certain investors. The company operates in the healthcare technology industry, providing an AI-powered platform for managing chronic conditions.

On July 10, 2026, DarioHealth Corp. announced that the temporary medical leave of absence of Steven Nelson, President and Chief Commercial Officer, was extended for an indefinite period. His responsibilities are currently being assumed by other members of the senior management team. DarioHealth Corp. is a digital health company that provides chronic condition management solutions.